Plaque

DENTSPLY SIRONA INC. (NASDAQ: XRAY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against DENTSPLY SIRONA Inc. (NASDAQ: XRAY)

Retrieved on: 
Wednesday, June 15, 2022
Audit, Securities Exchange Act of 1934, COVID-19, NEW, Company, Technology, Class, Achievement, Dentsply Sirona, Court, Degenerative disease, Audit committee, Defendant, The Legal 500, Lists of action films, Labour government, Plaque, Advertising, Investment, NASDAQ, XRAY, Anesthetic, News, District court, SEC, Board of directors, Board, Sirona, GLOBE, Disclosure, Committee on Finance, Tobacco, Security (finance)

NEW YORK, June 15, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Ohio and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Dentsply produces a wide array of dental supplies, ranging from anesthetics, plaque and gum disease prevention, tooth polishers, and artificial teeth.
  • As (former) executives of Dentsply, Defendants Donald M. Casey, Jr. (Casey) and Jorge Gomez (Gomez) were eligible for significant cash- and stock-based incentive compensation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CareDx, Spero, LMP Automotive, and Dentsply Sirona and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, June 14, 2022
New Drug Application, Mission statement, Company, Workforce, Sale, Review, COVID-19, Tebipenem, Superior, California superior courts, HBR, Marketing, Infection, Food, Income, Degenerative disease, Urinary tract infection, Spero, Population, LMP, NDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Relevant, Kidney, Audit committee, Class Action, Government, Physician, Justice, Patient, XRAY, Plaque, SEC, Complaint, CDNA, Anesthetic, Annual report, Medicare, Complicated, News, Treatment, Dentsply Sirona, FDA, Growth, ASP, GLOBE, Defendant, Risk, NASDAQ, Board, Lists of schools in England, Documentation, Pharmaceutical industry, Animal, Renewable energy, Audit, Medical device, Property management, Pyelonephritis, P.C

Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.

Key Points: 
  • Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • For more information on the LMP class action go to: https://bespc.com/cases/LMPX
    Dentsply is a dental equipment manufacturer with offices across the United States.
  • For more information on the Dentsply Sirona class action go to: https://bespc.com/cases/XRAY
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Mellow Premium Launches Dog Chews Made From Himalayan Yak Milk Exclusively For America

Retrieved on: 
Saturday, June 11, 2022
Human, Friends, Dental, Food, Mello, PETS, Immunity, Domestication, CEO, Environment, Energy, Founder, Health, Dog, Plaque, Parent, Founder CEO, Dental care, Animal husbandry, Dentistry, Himalayan

Apparently Mellow Premium aims to tap the North American organic pet food industry worth USD 4991.54

Key Points: 
  • Taking this view into consideration, we have launched the Mello Premium dog chews made from Yak Milk.
  • Himalayan Yak Milk Chew from Mellow Premium fulfills that requirement and provides multiple benefits that make it perfect for any dog.
  • Mellow Premium claims the following benefits for dogs with their Yak milk dog chews.
  • Good Dental Health: Dental care for dogs is a consistent affair but Mellow Premium claims that their Yak milk dog chews can easily help fight plaque and tartar.

New Liquid Core® SMILE™ Gum with Activated Charcoal and Hydroxyapatite

Retrieved on: 
Thursday, June 9, 2022
Zero, Tooth enamel, Dentistry, Earth's outer core, Degenerative disease, Glass, Activated carbon, WebMD, Meal, Xylitol, NIH, Coffee, National Smile Month, Diabetes, Health, Plaque, Ministry of Health & Wellness, Wellness, Widgery, Collection, Hydroxyapatite, Bacteria, Mayo Clinic, Clinical professor, Periodontal disease, CAGR, Gum arabic, Next

DENVER, June 9, 2022 /PRNewswire/ -- Liquid Core® Gum Company announced the release of Liquid Core SMILE™ Gum today, offering a just-brushed clean mouth after meals, or when brushing isn't convenient.  Featuring Activated Charcoal and Hydroxyapatite, a fluoride alternative, Liquid Core SMILE™ was formulated using ingredients clinically proven/shown to strengthen tooth enamel and improve oral health. Liquid Core SMILE™ Gum is part of the Liquid Core® Health & Wellness Collection. The launch of Liquid Core SMILE™ coincides with National Smile Month, a campaign focused on the benefits of good oral health.

Key Points: 
  • Chewing Gum After Meals Improves Oral Health, Provides Cognitive Boost
    DENVER, June 9, 2022 /PRNewswire/ -- Liquid Core Gum Company announced the release of Liquid Core SMILE Gum today, offering a just-brushed clean mouth after meals, or when brushing isn't convenient.
  • Featuring Activated Charcoal and Hydroxyapatite, a fluoride alternative, Liquid Core SMILE was formulated using ingredients clinically proven/shown to strengthen tooth enamel and improve oral health.
  • Liquid Core SMILE Gum is part of the Liquid Core Health & Wellness Collection.
  • Liquid Core Gum chewers understand the functional benefits of the brands, while Liquid Core SMILE offers an opportunity to bring people that do not currently chew gum into the functional gum category.

XRAY INVESTORS: August 1, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Thursday, June 9, 2022
Legal, Professional Services, Benchmark, Committee on Finance, Company, Audit committee, Anesthetic, Court, The National Law Journal, News, Security (finance), Degenerative disease, XRAY, Plaque, Board, Lists of schools in England, Audit, LLP, Dentsply Sirona, U.S. Securities and Exchange Commission, Tobacco

If you purchased Dentsply common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 1, 2022.

Key Points: 
  • If you purchased Dentsply common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 1, 2022.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.
  • The National Law Journal has recognized Lieff Cabraser as one of the nations top plaintiffs law firms for fourteen years.

Hoth Therapeutics Announces Extension of Washington University Alzheimer's Mouse Model Study with Alzheimer's Therapeutic HT-ALZ

Retrieved on: 
Thursday, June 9, 2022
Washington University School of Medicine, Washington University in St. Louis, Research, Doctor of Philosophy, Associate, Animal, Ageing, Annual report, Disease, Neurodegeneration, Organization, Female, U.S. Securities and Exchange Commission, Risk, Therapy, Memory, Brain, Male, AD, Private Securities Litigation Reform Act, Dementia, Plaque, NASDAQ, Learning, Alzheimer's disease, Rapunzel's Tangled Adventure (season 2), Pharmaceutical industry, Medical imaging, Hoth, Coronavirus, Neurology

NEW YORK, June 9, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has entered into an extension of its Sponsored Research Agreement with Washington University in St. Louis to support the continued research and development of HT-ALZ, a novel therapeutic for the treatment of Alzheimer's disease.

Key Points: 
  • Based on the data generated from the first set of Alzheimer mouse model studies, Hoth plans to continue investigating the effects of HT-ALZ on behavioral and pathological markers of Alzheimer's disease.
  • The chronic dosing studies will also include a broad range of HT-ALZ doses to determine if there are dose-dependent effects on behavioral outcomes.
  • Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life.
  • Although Hoth believes that the expectations reflected in the forward-looking statements are reasonable, Hoth cannot guarantee such outcomes.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against LMP, Dentsply Sirona, IonQ, and Energy Transfer and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 9, 2022
Transfer, HDD, Mission statement, Company, Transport, Complaint, Natural gas, Technology, Review, NYSE, Master limited partnership, Form 10-Q, IonQ, Research report, Income, Partnership, Energy Transfer Partners, Degenerative disease, Quantum, LMP, Relevant, Tuscarawas, Audit committee, FERC, XRAY, Plaque, SEC, Tuscarawas River, Energy, NGL, Enforcement, Anesthetic, Annual report, News, Federal Energy Regulatory Commission, Dentsply Sirona, GLOBE, Defendant, NASDAQ, Board, Lists of schools in England, P.C, Documentation, Medical device, Cryptocurrency, Renewable energy, Audit, Property management, Risk management

On this news, the Companys stock price fell $0.19, or 3.8%, to close at $4.81 per share on April 1, 2022.

Key Points: 
  • On this news, the Companys stock price fell $0.19, or 3.8%, to close at $4.81 per share on April 1, 2022.
  • The Company also disclosed that these errors may impact certain previously disclosed material weaknesses in the registrants controls over financial reporting.
  • For more information on the IonQ class action go to: https://bespc.com/cases/IONQ
    Energy Transfer is a Delaware company headquartered in Dallas, Texas.
  • For more information on the Energy Transfer class action go to: https://bespc.com/cases/ET
    About Bragar Eagel & Squire, P.C.

XRAY INVESTORS: August 1, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Wednesday, June 8, 2022
Legal, Professional Services, Benchmark, Committee on Finance, Company, Audit committee, Anesthetic, Court, The National Law Journal, News, Security (finance), Degenerative disease, XRAY, Plaque, Board, Lists of schools in England, Audit, LLP, Dentsply Sirona, U.S. Securities and Exchange Commission, Tobacco

If you purchased Dentsply common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 1, 2022.

Key Points: 
  • If you purchased Dentsply common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 1, 2022.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.
  • The National Law Journal has recognized Lieff Cabraser as one of the nations top plaintiffs law firms for fourteen years.

Oral-B and Straumann Partner on a Landmark Alliance for Scientific Education to Improve the Periodontal and Peri-Implant Health of Patients Worldwide

Retrieved on: 
Wednesday, June 8, 2022
Other Consumer, Health, Dental, Consumer, Degenerative disease, Type, Tooth loss, Group, University of Milan, Clear aligners, Ultimate tensile strength, Publication, Periodontal disease, American Academy of Periodontology, Gingivitis, Wound healing, Dentistry, Association, Habit, Artificial intelligence, Light-emitting diode, Battery, Type 2 diabetes, Solution, Cardiovascular disease, University of Bologna, Procter & Gamble, Specialization, Diagnosis, Peri-implantitis, Patient, COVID-19, American Academy, Debridement, Oral hygiene, University of Pisa, University, Gambling in Thailand, Plaque, Breast implant, Periodontology, Science, Adult, Dental hygienist, Research, Tooth, Maintenance, CADCAM, NUVO, Practitioner, Congress, Cosmetics, Straumann, Other Consumer, Health, Dental, Consumer

The alliance will set new standards in quality scientific education for dental professionals and help their patients achieve better long-term outcomes.

Key Points: 
  • The alliance will set new standards in quality scientific education for dental professionals and help their patients achieve better long-term outcomes.
  • The vision for the Oral-B Straumann Alliance is ambitious: an unwavering commitment to amplifying the importance of prevention through scientific education, helping dental professionals and their implant and periodontal patients achieve better outcomes.
  • The Sponsored Scientific Session Limiting periodontal and peri-implant diseases during and beyond the pandemic: from the chair to self-care.
  • Thus, this alliance should be cherished in order to simplify the life of our patients and provide additional benefits for their health.

Dental Floss Market is expected to display a steady growth by 2027|CAGR: 6%| UnivDatos Market Insights

Retrieved on: 
Tuesday, June 7, 2022
Internet, Statistics Canada, APAC, Dentistry, COVID-19, Database, Awareness, Oral hygiene, Growth, World Games, Juniper berry, Plaque, Shock, Consumer, Prevalence, Industry, Delta Dental, Enzyme, CAGR, USD, Health insurance, NOIDA

The dental floss market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The dental floss market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • The dental floss market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the dental floss market at the global and regional levels.
  • The Global Dental Floss Market is expected to grow at a CAGR of around 6% from 2021-2027.